1-11 of 11
Chung Hoow Kok, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapy-Related Myeloid Neoplasm Has a Distinct Pro-Inflammatory Bone Marrow Microenvironment and Delayed DNA Damage Repair

Monika M Kutyna, MSc, Li Yan A Wee, BSc (Hons), Sharon Paton, BSc, Dimitrios Cakouros, PhD, Agnieszka Arthur, PhD, Rakchha Chhetri, MBBS, Andreas W Schreiber, PhD, Chung Hoow Kok, PhD BSc, Deepak Singhal, MBBS,MDFRACP,FRCPA, Daniel Thomas, MD PhD, Timothy P. Hughes, MDMBBS,FRACP,FRCPA, David Campbell, PhD B.M.B.S., F.R.A.C.S., F.A.Oth.A, Stan Gronthos, PhD, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137277
Published: 2020
Journal Articles

A Combination of CD302 gene Expression and 3-Months BCR-ABL1 Level Predicts Inferior Achievement of Deep Molecular Response in CP-CML Patients Treated with Imatinib

Chung Hoow Kok, PhD BSc, Liu Liu, PhD BSc, David T Yeung, PhDBSc,FRACP,FRCPA,MBBS, Verity A Saunders, Phuong Dang, Timothy P. Hughes, MDMBBS,FRACP,FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 663.
https://doi.org/10.1182/blood-2019-125446
Published: 2019
Journal Articles

Integration of Multiple Bioassays Using Machine Learning to Identify High-Risk CP-CML Patients Treated with Frontline Imatinib

Chung Hoow Kok, PhD BSc, Sakrapee Paisitkriangkrai, PhD, David T Yeung, PhD BSc, FRACP, FRCPA MBBS, Liu Liu, PhD BSc, Verity A Saunders, Phuong Dang, Agnes S. M. Yong, MD PhD, Deborah L White, PhD, Timothy P. Hughes, MD MBBS, FRACP, FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 1728.
https://doi.org/10.1182/blood-2018-99-117633
Published: 2018
Journal Articles

In Vitro Modeling of Ph-like ALL Fusions Identifies Novel Kinase-Domain Mutations As Mode of TKI-Resistance - Implications for Targeted Therapy

Kartini Asari, Susan L Heatley, PhD MD, Teresa Sadras, PhD, Tamara M Leclercq, PhD, Stephen Fitter, PhD, Chung Hoow Kok, PhD, Andrew C W Zannettino, PhD, Timothy P. Hughes, MD FRACP, FRCPA, MBBS, Deborah L White, PhD FFSc (RCPA)
Journal: Blood
Blood (2016) 128 (22): 3957.
https://doi.org/10.1182/blood.V128.22.3957.3957
Published: 2016
Journal Articles

High Prevalence of Relapse in Australian Children with Ph-like Acute Lymphoblastic Leukemia Despite Risk Adapted Treatment

Susan L Heatley, PhD MD, Teresa Sadras, PhD, Eva Nievergall, PhD, Chung Hoow Kok, PhD, Phuong Dang, BSci (Hon), Kelly Quek, PhD, Nicola C Venn, Sarah Moore, BSc (Hon), FFSc (RCPA), Tamara Law, BSc (Hons), Anthea Ng, BAppSc, MSc, Murray D Norris, PhD, Tamas Revesz, MD PhD, Michael P Osborn, MBBS, Chris Fraser, FRACP, MBBS, MPH, Frank Alvaro, MBBS, FRACP, Glenn M Marshall, MBBS, MD FRACP, Luciano Dalla Pozza, MBBS, FRACP, Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Charles G. Mullighan, MBBS, MSc, MD, Rosemary Sutton, PhD, Deborah L White, PhD FFSc (RCPA)
Journal: Blood
Blood (2015) 126 (23): 1419.
https://doi.org/10.1182/blood.V126.23.1419.1419
Published: 2015
Journal Articles

High Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) Transcriptional Activity Reduces Active Influx of Imatinib and Kinase Inhibition in CML Cells

Jueqiong WANG, PhD, Chung Hoow Kok, PhD, Tamara M Leclercq, PhD, Verity A Saunders, BSc (Hons), Richard J D'Andrea, PhD, Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Deborah L White, PhD FFSc (RCPA)
Journal: Blood
Blood (2015) 126 (23): 2770.
https://doi.org/10.1182/blood.V126.23.2770.2770
Published: 2015
Journal Articles

A 20 Gene Expression Signature That Predicts Early Molecular Response Failure in Chronic Phase CML Patients Treated with Frontline Imatinib

Chung Hoow Kok, PhD, Tamara M Leclercq, PhD, Dale Watkins, PhD, David T Yeung, BSc, MBBS, FRACP, FRCPA, Verity A Saunders, BSc (Hons), Deborah L White, PhD FFSc (RCPA), Timothy P. Hughes, MD MBBS, FRACP, FRCPA
Journal: Blood
Blood (2015) 126 (23): 596.
https://doi.org/10.1182/blood.V126.23.596.596
Published: 2015
Journal Articles

Role Of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Its Ligands In The Regulation Of Functional OCT-1 Activity In CML Cells

Jueqiong Wang, PhD, Chung Hoow Kok, PhD, Richard J. D'Andrea, PhD, Timothy P. Hughes, MD, MBBS, Deborah L. White, PhD, FFSc(RCPA)
Journal: Blood
Blood (2013) 122 (21): 1470.
https://doi.org/10.1182/blood.V122.21.1470.1470
Published: 2013
Journal Articles

Global DNA Methylation Analysis Identifies Key Pathway Differences Between Poor (Low OCT-1 Activity) and Standard Risk CP-CML Patients At Diagnosis

Dale B. Watkins, B.Sc. (Hons), Chung Hoow Kok, PhD, Richard J. D'Andrea, PhD, Timothy P. Hughes, MD, MBBS, Deborah L. White, PhD, FFSc(RCPA)
Journal: Blood
Blood (2012) 120 (21): 3730.
https://doi.org/10.1182/blood.V120.21.3730.3730
Published: 2012
Journal Articles

Non-Steroidal Anti-Inflammatory Drugs and Imatinib; Drug Interactions That May Impact Efficacy,

Jueqiong Wang, MMed, Timothy P Hughes, MD, MBBS, Chung Hoow Kok, PhD, Verity A Saunders, BScHons, Amity Frede, BScHons, Kelvin GrootObbink, BScHons, Michael Philip Osborn, MBBS, Andrew A Somogyi, PhD, Richard J D'Andrea, PhD, Deborah L. White, PhD. FFSc(RCPA)
Journal: Blood
Blood (2011) 118 (21): 3501.
https://doi.org/10.1182/blood.V118.21.3501.3501
Published: 2011
Journal Articles

Differential Lineage Involvement Between Very Low and Higher OCT-1 Activity Chronic-Phase CML Patients

Dale B. Watkins, B.Sc. (Hons), Chung Hoow Kok, PhD, Timothy P. Hughes, MD, MBBS, Cassandra Slader, PhD, Richard D'Andrea, PhD, Deborah L. White, PhD. FFSc(RCPA)
Journal: Blood
Blood (2011) 118 (21): 1675.
https://doi.org/10.1182/blood.V118.21.1675.1675
Published: 2011